“C-Terminal-PEDF Reduces IC50 Doses and Chemoresistant Population of CD133 and BCRP1-Positve Cancer Stem Like Cells”, J. Anal. Oncol., vol. 2, no. 4, pp. 195–208, Dec. 2013, doi: 10.6000/1927-7229.2013.02.04.2.